Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Nevus psiloliparus lacks mature hair follicles but keeps other skin structures intact.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Removing the thymoma improved the patient's alopecia areata, suggesting a possible link between the two.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

Blocking LFA-1 prevents hair loss in mice.

The document describes previously unreported unique skin changes in a rare genetic disorder called Hereditary mucoepithelial dysplasia.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

The study identified key immune cell differences between mild and severe alopecia areata.

A man's skin condition was misdiagnosed and later identified as a rare type of skin cancer, which did not improve with treatment.

Interleukin-15 can help hair growth and protect hair follicles.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Two boys had a rare skin condition needing to be differentiated from similar disorders, with unclear inheritance due to few cases.

A woman with a rare hair loss condition developed skin cancer in the bald area.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Generalized trichoepitheliomas with hair loss may indicate myasthenia gravis.